Kidney transplant patients: which drug keeps you healthier?
NCT ID NCT06044493
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two similar immunosuppressant drugs, MYREPTIC-N® and MY-REPT®, in 158 adults who had a kidney transplant at least a year ago. The goal was to see how well each drug prevented organ rejection, graft loss, or death. Participants continued their usual anti-rejection medicines during the trial. The results help doctors choose the best option for long-term transplant care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea